OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Headache and Pain is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition	600
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II	297
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis	130
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine	112
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study	100
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials	79
Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache	72
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation	67
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency	62
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients	61
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China	54
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study	54
Debate: Are cluster headache and migraine distinct headache disorders?	53
Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia	53
Measuring interictal burden among people affected by migraine: a descriptive survey study	46
Diagnostic criteria for acute headache attributed to ischemic stroke and for sentinel headache before ischemic stroke	44
Abnormalities in resting-state EEG microstates are a vulnerability marker of migraine	43
Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks	42
CGRP and PACAP-38 play an important role in diagnosing pediatric migraine	41
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine	37
One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey	37
Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury	36
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results	36
A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States	35
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study	34

Hypoperfusion in nucleus accumbens in chronic migraine using 3D pseudo-continuous arterial spin labeling imaging MRI	34
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study	33
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting	33
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phas	32
Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray with episodic and chronic migraine: a proton magnetic resonance spectroscopy study	32
Attenuated alpha oscillation and hyperresponsiveness reveals impaired perceptual learning in migraineurs	32
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain	32